2023 annual financial data
Heron Therapeutics 2023 Operating margin
Direct answer
Operating margin was -87.07%.
Operating income was -110,615,000 USD and net income was -110,559,000 USD.
Operating cash flow was -58,789,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 127,044,000 USD
- Operating income
- -110,615,000 USD
- Net income
- -110,559,000 USD
- Operating cash flow
- -58,789,000 USD